These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38413979)

  • 1. Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer.
    Naro C; Antonioni A; Medici V; Caggiano C; Jolly A; de la Grange P; Bielli P; Paronetto MP; Sette C
    J Exp Clin Cancer Res; 2024 Feb; 43(1):58. PubMed ID: 38413979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy-induced stress response is associated with downregulation of pre-mRNA splicing in cancer cells.
    Anufrieva KS; Shender VО; Arapidi GP; Pavlyukov MS; Shakhparonov MI; Shnaider PV; Butenko IO; Lagarkova MA; Govorun VM
    Genome Med; 2018 Jun; 10(1):49. PubMed ID: 29950180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancer.
    Zhang D; Hu Q; Liu X; Ji Y; Chao HP; Liu Y; Tracz A; Kirk J; Buonamici S; Zhu P; Wang J; Liu S; Tang DG
    Nat Commun; 2020 Apr; 11(1):2089. PubMed ID: 32350277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the Cyclin K-CDK12 complex induces DNA damage and increases the effect of androgen deprivation therapy in prostate cancer.
    Frei K; Schecher S; Daher T; Hörner N; Richter J; Hildebrand U; Schindeldecker M; Witzel HR; Tsaur I; Porubsky S; Gaida MM; Roth W; Tagscherer KE
    Int J Cancer; 2024 Mar; 154(6):1082-1096. PubMed ID: 37916780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SF3B2-Mediated RNA Splicing Drives Human Prostate Cancer Progression.
    Kawamura N; Nimura K; Saga K; Ishibashi A; Kitamura K; Nagano H; Yoshikawa Y; Ishida K; Nonomura N; Arisawa M; Luo J; Kaneda Y
    Cancer Res; 2019 Oct; 79(20):5204-5217. PubMed ID: 31431456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of RNA splicing associated with Wnt signaling pathway using FD-895 and pladienolide B.
    Kumar D; Kashyap MK; Yu Z; Spaanderman I; Villa R; Kipps TJ; La Clair JJ; Burkart MD; Castro JE
    Aging (Albany NY); 2022 Mar; 14(5):2081-2100. PubMed ID: 35230971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel truncated androgen receptor (AR) mutants including unreported pre-mRNA splicing variants in the 22Rv1 hormone-refractory prostate cancer (PCa) cell line.
    Marcias G; Erdmann E; Lapouge G; Siebert C; Barthélémy P; Duclos B; Bergerat JP; Céraline J; Kurtz JE
    Hum Mutat; 2010 Jan; 31(1):74-80. PubMed ID: 19830810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid nanoparticles to silence androgen receptor variants for prostate cancer therapy.
    Quick J; Santos ND; Cheng MHY; Chander N; Brimacombe CA; Kulkarni J; van der Meel R; Tam YYC; Witzigmann D; Cullis PR
    J Control Release; 2022 Sep; 349():174-183. PubMed ID: 35780952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen-dependent alternative mRNA isoform expression in prostate cancer cells.
    Munkley J; Maia TM; Ibarluzea N; Livermore KE; Vodak D; Ehrmann I; James K; Rajan P; Barbosa-Morais NL; Elliott DJ
    F1000Res; 2018; 7():1189. PubMed ID: 30271587
    [No Abstract]   [Full Text] [Related]  

  • 10. Unannotated splicing regulatory elements in deep intron space.
    Conboy JG
    Wiley Interdiscip Rev RNA; 2021 Sep; 12(5):e1656. PubMed ID: 33887804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-mRNA splicing repression triggers abiotic stress signaling in plants.
    Ling Y; Alshareef S; Butt H; Lozano-Juste J; Li L; Galal AA; Moustafa A; Momin AA; Tashkandi M; Richardson DN; Fujii H; Arold S; Rodriguez PL; Duque P; Mahfouz MM
    Plant J; 2017 Jan; 89(2):291-309. PubMed ID: 27664942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The DNA/RNA helicase DHX9 contributes to the transcriptional program of the androgen receptor in prostate cancer.
    Chellini L; Pieraccioli M; Sette C; Paronetto MP
    J Exp Clin Cancer Res; 2022 May; 41(1):178. PubMed ID: 35590370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minor intron splicing revisited: identification of new minor intron-containing genes and tissue-dependent retention and alternative splicing of minor introns.
    Olthof AM; Hyatt KC; Kanadia RN
    BMC Genomics; 2019 Aug; 20(1):686. PubMed ID: 31470809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AIbZIP, a novel bZIP gene located on chromosome 1q21.3 that is highly expressed in prostate tumors and of which the expression is up-regulated by androgens in LNCaP human prostate cancer cells.
    Qi H; Fillion C; Labrie Y; Grenier J; Fournier A; Berger L; El-Alfy M; Labrie C
    Cancer Res; 2002 Feb; 62(3):721-33. PubMed ID: 11830526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The splicing modulator sulfonamide indisulam reduces AR-V7 in prostate cancer cells.
    Melnyk JE; Steri V; Nguyen HG; Hann B; Feng FY; Shokat KM
    Bioorg Med Chem; 2020 Oct; 28(20):115712. PubMed ID: 33069070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids.
    Cesari E; Ciucci A; Pieraccioli M; Caggiano C; Nero C; Bonvissuto D; Sillano F; Buttarelli M; Piermattei A; Loverro M; Camarda F; Greco V; De Bonis M; Minucci A; Gallo D; Urbani A; Vizzielli G; Scambia G; Sette C
    J Exp Clin Cancer Res; 2023 May; 42(1):126. PubMed ID: 37202753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KLF6 loss of function in human prostate cancer progression is implicated in resistance to androgen deprivation.
    Liu X; Gomez-Pinillos A; Loder C; Carrillo-de Santa Pau E; Qiao R; Unger PD; Kurek R; Oddoux C; Melamed J; Gallagher RE; Mandeli J; Ferrari AC
    Am J Pathol; 2012 Sep; 181(3):1007-16. PubMed ID: 22819534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The RNA-binding protein hnRNPLL induces a T cell alternative splicing program delineated by differential intron retention in polyadenylated RNA.
    Cho V; Mei Y; Sanny A; Chan S; Enders A; Bertram EM; Tan A; Goodnow CC; Andrews TD
    Genome Biol; 2014 Jan; 15(1):R26. PubMed ID: 24476532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of kinase gene expression and splicing profile in prostate cancer with RNA-Seq data.
    Feng H; Li T; Zhang X
    BMC Genomics; 2018 Aug; 19(Suppl 6):564. PubMed ID: 30367578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-Associated Perturbations in Alternative Pre-messenger RNA Splicing.
    Shkreta L; Bell B; Revil T; Venables JP; Prinos P; Elela SA; Chabot B
    Cancer Treat Res; 2013; 158():41-94. PubMed ID: 24222354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.